Analyst Research: Rexahn Pharmaceuticals Inc (RNN)

RNN on American Stock Exchange

0.76USD
30 Jul 2014
Price Change (% chg)

$0.04 (+5.34%)
Prev Close
$0.73
Open
$0.73
Day's High
$0.77
Day's Low
$0.73
Volume
1,340,460
Avg. Vol
1,939,171
52-wk High
$1.85
52-wk Low
$0.36

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - REXAHN PHARMACEUTICALS INC. (RNN-A) 29 Jul 2014 Thomson Reuters Stock Report 11 25.00
"The Economy Matters" Report for RNN: the economy's impact on RNN's price and risk, featuring the powerful Economic Climate Rating 28 Jul 2014 MacroRisk Analytics/EconomicInvestor 7 25.00
ValuEngine Rating and Forecast Report for RNN 27 Jul 2014 ValuEngine, Inc. 11 25.00
REXAHN PHARMACEUTICALS INC (RNN) 12-months forecast 25 Jul 2014 Pechala's Reports 1 15.00
REXAHN PHARMACEUTICALS INC (RNN) - REPORT FOR ACTIVE TRADERS 25 Jul 2014 Pechala's Reports 1 25.00
Rexahn Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 25 Jul 2014 Reuters Investment Profile 12 20.00
Value Graph: REXAHN PHARMA -- RNN 24 Jul 2014 Ford Investor Services, Inc. 1 12.00
REXAHN PHARMACT (RNN) Zacks Company Snapshot 24 Jul 2014 Zacks Investment Research Inc. 1 12.00
REXAHN PHARMACT (RNN) Zacks Company Snapshot 23 Jul 2014 Zacks Investment Research Inc. 1 12.00
REXAHN PHARMACT (RNN) Zacks Company Snapshot 22 Jul 2014 Zacks Investment Research Inc. 1 12.00
 
Name Age Since Current Position

Chang Ahn

61 2013 Chairman of the Board, Chief Scientist

Rakesh Soni

57 2009 President, Chief Operating Officer

Peter Suzdak

54 2013 Chief Executive Officer

Tae Jeong

2012 Chief Financial Officer, Secretary

Mark Carthy

50 2014 Director
Search Stocks